ID: ALA3889177
Type: Binding
Description: Biological Assay: Recombinant human factor B (expressed in drosophila cells and purified using standard methods) labeled with biotin (10 nM), europium-labeled streptavidin (5 nM) and (+) or (−)-2-((1E,3E,5E)-5-(1-(6-((2-(3-(4-((R)-3-amino-3-phenylpropanoyl)-1-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-2-yl)phenoxy)ethyl)amino)-6-oxohexyl)-3,3-dimethyl-5-sulfoindolin-2-ylidene)penta-1,3-dien-1-yl)-1-ethyl-3,3-dimethyl-5-sulfo-3H-indol-1-ium (Biological Example 2.6, 240 nM activity against factor B when tested using the assay of Biological Example 1) (75 nM) were incubated with test compound at various concentrations up to 2 hours at room temperature in 20 mM Tris/HCl, pH 7.4, 0.005% (v/v) Tween20.The time-gated decrease in fluorescence intensity related to the competition between labeled and unlabeled factor B ligands was recorded at both 620 nm and 665 nm, 70 μs after excitation at 337 nm using a microplate spectrofluorimeter.
Format: BAO_0000219
Target: Complement factor B(ALA5731)
Document: ALA3886977
BindingDB Source: 8478
Bioactivity
Activity Types for Assay ALA3889177
IC50
Parent Molecular Weight | ALogP | Polar Surface Area |
---|---|---|
414.39 | 3.65 | 3.65 |
399.38 | 3.98 | 3.98 |
360.42 | 3.11 | 3.11 |
347.38 | 2.88 | 2.88 |
343.39 | 3.58 | 3.58 |
357.42 | 3.75 | 3.75 |
358.45 | 3.66 | 3.66 |
345.41 | 3.95 | 3.95 |
361.41 | 3.54 | 3.54 |
333.35 | 2.71 | 2.71 |
400.36 | 3.39 | 3.39 |
346.39 | 2.85 | 2.85 |
410.40 | 4.26 | 4.26 |